Business Description
LB Pharmaceuticals is a New York-based company focused on creating new medicines for people living with serious mental health conditions, including schizophrenia and bipolar depression. Its main drug candidate, LB-102, is taken by mouth and is being tested in advanced clinical trials for schizophrenia, with earlier studies already completed for bipolar depression. Founded in 2015, the company is working to bring meaningful treatment options to patients with few alternatives.
